Olympus Corp. (7733) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.32 M

Shareholding (Mar 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a fall in Net Sales of -12.06%, the company declared Very Negative results in Jun 25

The company has declared negative results in Jan 70 after 3 consecutive negative quarters
DEBT-EQUITY RATIO (HY) Highest at 4.23 %
INTEREST(Q) At JPY 1,156 MM has Grown at 112.5%
NET PROFIT(Q) At JPY 8,991 MM has Fallen at -50.52%

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 2,132,426 Million (Large Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.03%

Debt Equity

0.04

Return on Equity

16.70%

Price to Book

2.91

Revenue and Profits:

Net Sales:

206,512 Million

(Quarterly Results - Jun 2025)

Net Profit:

8,991 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

11.02%

6 Months

4.27%

1 Year

-15.03%

2 Years

-3.66%

3 Years

-24.33%

4 Years

-17.5%

5 Years

-9.25%

Olympus Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Olympus Corp. Hits Day High with Strong 3.27% Intraday Surge

Olympus Corp. has experienced significant stock activity, achieving an intraday high and outperforming the Japan Nikkei 225 over the past week. Despite a year-to-date decline, the company maintains strong fundamentals, including a solid Return on Equity and positive operating cash flow for three consecutive quarters.

Olympus Corp. Hits Day Low at JPY 1,790 Amid Price Pressure

Olympus Corp. faced a decline on October 14, 2025, contrasting with the Japan Nikkei 225's performance. The company has seen a decrease over the past week and month, with a significant year-to-date drop. Despite these challenges, Olympus shows strong long-term fundamentals and positive quarterly results.

Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,870.50

Olympus Corp. faced a decline on October 8, 2025, amid ongoing volatility, with a year-to-date drop of 20.8%. Despite recent challenges, the company maintains strong long-term fundamentals, including a solid Return on Equity and low Debt to EBITDA ratio, alongside positive operating cash flow and growth in operating profit.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.58%

EBIT Growth (5y)

14.74%

EBIT to Interest (avg)

21.20

Debt to EBITDA (avg)

0.43

Net Debt to Equity (avg)

-0.03

Sales to Capital Employed (avg)

0.91

Tax Ratio

26.02%

Dividend Payout Ratio

19.42%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

22.60%

ROE (avg)

18.96%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.91

EV to EBIT

11.51

EV to EBITDA

8.50

EV to Capital Employed

2.97

EV to Sales

2.17

PEG Ratio

0.06

Dividend Yield

0.03%

ROCE (Latest)

25.82%

ROE (Latest)

23.79%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -12.06% vs 13.05% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -39.19% vs 9.64% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "206,512.00",
          "val2": "234,821.00",
          "chgp": "-12.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29,156.00",
          "val2": "54,449.00",
          "chgp": "-46.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,156.00",
          "val2": "2,173.00",
          "chgp": "-46.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-6,019.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,991.00",
          "val2": "14,786.00",
          "chgp": "-39.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.70%",
          "val2": "159.20%",
          "chgp": "-9.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 7.73% vs 4.97% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 235.95% vs -74.59% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "997,332.00",
          "val2": "925,752.00",
          "chgp": "7.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "252,494.00",
          "val2": "215,277.00",
          "chgp": "17.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,821.00",
          "val2": "5,809.00",
          "chgp": "-17.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-23,539.00",
          "val2": "-86,867.00",
          "chgp": "72.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117,800.00",
          "val2": "35,065.00",
          "chgp": "235.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.50%",
          "val2": "161.30%",
          "chgp": "2.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

206,512.00

234,821.00

-12.06%

Operating Profit (PBDIT) excl Other Income

29,156.00

54,449.00

-46.45%

Interest

1,156.00

2,173.00

-46.80%

Exceptional Items

0.00

-6,019.00

100.00%

Consolidate Net Profit

8,991.00

14,786.00

-39.19%

Operating Profit Margin (Excl OI)

62.70%

159.20%

-9.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -12.06% vs 13.05% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -39.19% vs 9.64% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

997,332.00

925,752.00

7.73%

Operating Profit (PBDIT) excl Other Income

252,494.00

215,277.00

17.29%

Interest

4,821.00

5,809.00

-17.01%

Exceptional Items

-23,539.00

-86,867.00

72.90%

Consolidate Net Profit

117,800.00

35,065.00

235.95%

Operating Profit Margin (Excl OI)

186.50%

161.30%

2.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 7.73% vs 4.97% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 235.95% vs -74.59% in Mar 2024

All Annual Results

Company CV

About Olympus Corp.

Olympus Corp.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Olympus Corp.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

With a fall in Net Sales of -12.06%, the company declared Very Negative results in Jun 25

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Olympus Corp. Hits Day High with Strong 3.27% Intraday Surge

Olympus Corp. Hits Day Low at JPY 1,790 Amid Price Pressure

Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,870.50

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Mar'25

About Olympus Corp.

Company Coordinates